Sharemaestro Newsreel

Spectral AI (NASDAQ:MDAI) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Spectral AI (NASDAQ:MDAI) announced quarterly earnings, reporting a loss of $0.13 per share, beating the consensus estimate by $0.01. Despite revenue of $3.52 million falling short of analysts' forecasts, the company received FDA clearance for its DeepView burn-assessment system and reiterated its full-year revenue …

NeuroPace (NASDAQ:NPCE) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Koninklijke Philips N.V. (PHG) stock price, news, quote and history

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Brinker International (EAT [https://seekingalpha.com/symbol/EAT]) * Amcor plc (AMCR [https://seekingalpha.com/symbol/AMCR]) * Jumia Technologies AG (JMIA [https://seekingalpha.com/symbol/JMIA]) Other earnings slated for release before Wednesday's …

Form 8K Vivos Therapeutics Inc For: 11 August By Investing.com

This article reports that Vivos Therapeutics Inc filed a Form 8K on August 11. It's a brief financial news item from Investing.com, noting the filing for the company with the stock symbol VVOS.

Owlet (NYSE:OWLT) Posts Earnings Results, Beats Estimates By $0.29 EPS

Earnings call transcript: NeuroPace tops Q2 2026 estimates, shares slip after hours

NeuroPace reported Q2 2026 results that exceeded Wall Street expectations for both earnings and revenue, but its shares fell in after-hours trading. The company posted a narrower adjusted loss and 17% revenue growth, driven by strong RNS System sales. Management raised full-year revenue and …

Vivos Therapeutics Strengthens IP for Sleep Apnea Devices

PACIFIC BIOSCIENCES (PACB) CEO granted 1.97M options and 489K RSUs

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) CEO Mark Van Oene was granted 1.97 million stock options and 489,130 Restricted Stock Units (RSUs) on August 10, 2026. The stock options have an exercise price of $1.15 per share and vest over 36 monthly installments, while …

Does Strong Q1 Results And VASCADE Data Shift The Bull Case For Haemonetics (HAE)?

Haemonetics Corporation reported stronger-than-expected Q1 results with increased sales and diluted EPS, along with positive new Emory University study data reinforcing the safety and efficiency of its VASCADE MVP XL venous vascular closure system. These developments, particularly the VASCADE data, are seen as significant …

Smith & Nephew (SNN) Q2 2026 Earnings Call Transcript

Neuropace earnings beat by $0.03, revenue topped estimates

NeuroPace, Inc. (NPCE) Reports Q2 Loss, Tops Revenue Estimates

NeuroPace, Inc. (NPCE) reported a Q2 loss of $0.18 per share, exceeding the Zacks Consensus Estimate of a $0.19 loss and showing an improvement from a $0.26 loss a year ago. The company also surpassed revenue estimates, posting $22.83 million against a consensus of …

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30. The numbers arrive as the company works its way back from a cyber incident that …

Insulet Corp. stock outperforms competitors on strong trading day

Insulet Corp. (PODD) saw its stock rise 1.30% to $144.70 on Tuesday, marking its fourth consecutive day of gains. This performance outpaced the broader market, as the S&P 500 Index and Dow Jones Industrial Average both experienced declines.

Earnings call transcript: SINTX posts Q2 2026 revenue growth but shares slip after hours

Sintx Technologies reported significant revenue growth of 199% year-over-year in Q2 2026, reaching $452,000, driven by increased product sales and improved gross margins. The company highlighted over $3.2 million in new purchase orders for contract manufacturing and initial commercial revenue from its SINAPTIC Foot …

Owlet, Inc. (OWLT) Q2 Earnings and Revenues Beat Estimates

Form 8K Intelligent Bio Solutions Inc For: 11 August By Investing.com

This article announces that Intelligent Bio Solutions Inc. filed a Form 8K on August 11. The filing is a standard regulatory disclosure for significant events that shareholders should know about. The brief piece indicates that Investing.com is the source of this financial news.

Intelligent Bio Solutions completes multi-site study, targets FDA 510(k) submission in H2 2026

Intelligent Bio Solutions (INBS) has completed its multi-site Method Comparison Study for its Intelligent Fingerprinting Drug Screening System. All clinical data collection for its FDA 510(k) program is now complete. The company is currently analyzing data and preparing the submission package, aiming for FDA …

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept misled investors by failing to disclose …

SINTX TECHNOLOGIES ($SINT) Releases Q2 2026 Earnings

Mobia Medical (MOBI) doubles revenue as IPO cash lifts balance sheet

Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants

Neuronetics Inc. reported increased revenues for Q2 and H1 2026, primarily driven by its Greenbrook segment, and narrowed its net loss. However, the company flagged substantial doubt about its ability to continue as a going concern due to a projected failure to meet a …

SS Innovations International, Inc. expected to post a loss of 2 cents a share - Earnings Preview

SS Innovations International, Inc. is projected to report a loss of 2 cents per share, according to an earnings preview. The article indicates this financial expectation for the company.

Mobia Medical Reports Second Quarter 2026 Financial Results

Mobia Medical, Inc. announced strong financial results for the second quarter of 2026, with revenue more than doubling year-over-year to $13.5 million, reflecting significant growth in adoption of its Vivistim System. The company also reported a gross margin of 83.2% and a net loss …

Mobia Medical: Q2 Earnings Snapshot

IceCure Medical (ICCM) names David Salton to board as independent director

IceCure Medical Ltd. (ICCM) has appointed David Salton as an independent Class II director to its Board, effective until the 2027 annual general meeting. This appointment follows the resignation of Vincent Chun Hung Chan, which the company stated was not due to any disagreements. …

TELA Bio (NASDAQ: TELA) faces going concern doubt amid debt covenants and cash burn

TELA Bio (NASDAQ: TELA) is facing substantial doubt about its ability to continue as a going concern due to widening losses, significant cash burn, and forecasted noncompliance with debt covenants. The medical technology company reported flat revenue and an increased net loss for Q2 …

TELA Bio, Inc. 2026: Revenue $19.29M, EPS ($0.2) — 10-Q Summary

TELA Bio, Inc. reported its 2026 quarterly results with revenue of $19.29M, a net loss of ($11.26M), and diluted loss per share of ($0.2). This represents a decline in revenue compared to the prior year, primarily due to lower OviTex PRS sales, despite an …

NeuroPace Inc 2Q 2026: Revenue $22.8M, Net loss $(6.2M), EPS $(0.18) — 10-Q Summary

NeuroPace Inc reported its second-quarter 2026 results, showing a revenue of $22.8 million, a 17% increase year-over-year. The company posted a net loss attributable to common stockholders of $(6.2) million, with a diluted loss per share of $(0.18), an improvement from $(0.26) in the …

CVRx, Inc. Investors With Losses Should Contact Block & Leviton About Securities Fraud Investigation

Block & Leviton is investigating CVRx, Inc. (Nasdaq:CVRX) for potential securities law violations after the company cut its full-year revenue guidance, citing sales-force issues, elevated turnover, and a prolonged reimbursement challenge. The investigation also concerns a civil investigative demand from the Department of Justice …

Tactile Systems Technology (NASDAQ:TCMD) Issues Earnings Results

Tactile Systems Technology (NASDAQ:TCMD) reported strong earnings, beating analyst expectations with $0.34 EPS against a $0.14 consensus and revenue of $85.70 million. Despite the positive results, the stock experienced a slight dip of 1.2%. Analysts maintain a "Moderate Buy" rating with a target price …

Boston Scientific (BSX) CFO adds 9,908 shares through discretionary 401(k) rebalancing

Jonathan Monson, EVP and CFO of Boston Scientific (BSX), acquired 9,908 shares of common stock on August 10, 2026, at $50.46 per share. This acquisition was a result of a discretionary rebalancing election within the company’s 401(k) Retirement Savings Plan. Following this transaction, Monson …

Medtronic PLC stock outperforms competitors on strong trading day

Medtronic PLC (MDT) stock rallied 1.42% to $90.68 on Tuesday, outperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average both saw declines. This marks the third consecutive day of gains for Medtronic's stock.

CVRx, Inc. (CVRX) Presents at Canaccord Genuity's 46th Annual Growth Conference - Slideshow

Top Research Reports for Meta, Texas Instruments & CrowdStrike

Tuesday, August 11, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Texas Instruments Inc. (TXN) and CrowdStrike Holdings, Inc. (CRWD), as well …